Literature DB >> 28919371

Perinatal deficiency in dietary omega-3 fatty acids potentiates sucrose reward and diet-induced obesity in mice.

Stéphanie Auguste1, Sandeep Sharma2, Alexandre Fisette1, Maria F Fernandes2, Caroline Daneault3, Christine Des Rosiers4, Stephanie Fulton5.   

Abstract

Insufficient dietary intake of essential omega-3 polyunsaturated fatty acids (N-3), especially during critical stages of development, is well-associated with negative neurological and metabolic consequences. The increased availability and intake of foods rich in saturated fat coincides with reduced N-3 consumption, yet how N-3 dietary deficiency during perinatal development modulates motivation for palatable food and interacts with a high-fat diet to affect body weight and emotional states is not clear. Pregnant C57Bl6 mice and pups were subjected to diets either deficient or adequate (control) in N-3 until postnatal day 21. Adult male N-3 deficient or control offspring were tested in a progressive ratio operant task for sucrose motivated behavior or given prolonged access to a saturated high-fat diet or chow followed by measures of energy balance and anxiety-like behavior in the elevated-plus maze and open field test. Brain fatty acid profiles were measured via gas chromatography mass spectrometry. Perinatal dietary N-3 deficiency lowered brain N-3 levels, augmented the rewarding effects of sucrose, heightened diet-induced weight gain and fat mass accumulation and diminished spontaneous physical activity. Finally, perinatal N-3 deficiency increased anxiety-like behaviour independent of diet in the open field but not in the elevated-plus maze test. Insufficient dietary N-3 during critical periods of developmental can amplify the obesogenic effects of saturated fat intake, enhance motivated behaviour for palatable foods and may elicit negative emotional states that can perpetuate overeating and obesity.
Copyright © 2017 ISDN. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Energy balance; Food-motivated behaviour; Lipids; Obesity; Perinatal

Mesh:

Substances:

Year:  2017        PMID: 28919371     DOI: 10.1016/j.ijdevneu.2017.09.003

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  6 in total

1.  Maternal Docosahexaenoic Acid Status during Pregnancy and Its Impact on Infant Neurodevelopment.

Authors:  Sanjay Basak; Rahul Mallick; Asim K Duttaroy
Journal:  Nutrients       Date:  2020-11-25       Impact factor: 5.717

2.  Nutritional Supplementation Reduces Lesion Size and Neuroinflammation in a Sex-Dependent Manner in a Mouse Model of Perinatal Hypoxic-Ischemic Brain Injury.

Authors:  Myrna J V Brandt; Cora H Nijboer; Isabell Nessel; Tatenda R Mutshiya; Adina T Michael-Titus; Danielle S Counotte; Lidewij Schipper; Niek E van der Aa; Manon J N L Benders; Caroline G M de Theije
Journal:  Nutrients       Date:  2021-12-30       Impact factor: 5.717

Review 3.  Perinatal Polyunsaturated Fatty Acid Status and Obesity Risk.

Authors:  Hans Demmelmair; Berthold Koletzko
Journal:  Nutrients       Date:  2021-10-29       Impact factor: 5.717

Review 4.  Perinatal diet and offspring anxiety: A scoping review.

Authors:  Sasha Monteiro; Yousef Sadat Nejad; Monique Aucoin
Journal:  Transl Neurosci       Date:  2022-09-06       Impact factor: 1.264

5.  Maternal diet in pregnancy is associated with differences in child body mass index trajectories from birth to adolescence.

Authors:  Carmen Monthé-Drèze; Sheryl L Rifas-Shiman; Izzuddin M Aris; Nitin Shivappa; James R Hebert; Sarbattama Sen; Emily Oken
Journal:  Am J Clin Nutr       Date:  2021-04-06       Impact factor: 7.045

6.  Maternal dietary imbalance between omega-6 and omega-3 fatty acids triggers the offspring's overeating in mice.

Authors:  Nobuyuki Sakayori; Masanori Katakura; Kei Hamazaki; Oki Higuchi; Kazuki Fujii; Ryoji Fukabori; Yoshio Iguchi; Susumu Setogawa; Keizo Takao; Teruo Miyazawa; Makoto Arita; Kazuto Kobayashi
Journal:  Commun Biol       Date:  2020-08-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.